To investigate the effect of ITGA2 on the immune microenvironment of pancreatic cancer, we conducted immunohistochemistry to detect the expression of ITGA2, CD4+T cells, and CD8+T cells in tumor tissues. This evidence concerns the gene CD8A and familial pancreatic carcinoma.